Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction
Authors
Keywords
-
Journal
Clinical Research in Cardiology
Volume 101, Issue 2, Pages 117-124
Publisher
Springer Nature
Online
2011-10-21
DOI
10.1007/s00392-011-0372-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ClearWay™ RX - Rapid exchange therapeutic perfusion catheter
- (2011) Smriti Saraf et al. EuroIntervention
- Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: Design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial
- (2010) Holger Thiele et al. AMERICAN HEART JOURNAL
- Intracoronary Eptifibatide Bolus Administration During Percutaneous Coronary Revascularization for Acute Coronary Syndromes With Evaluation of Platelet Glycoprotein IIb/IIIa Receptor Occupancy and Platelet Function
- (2010) Albert J. Deibele et al. CIRCULATION
- Intracoronary Versus Intravenous Administration of Abciximab in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention With Thrombus Aspiration
- (2010) Youlan L. Gu et al. CIRCULATION
- Intracoronary versus intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: 6-month effects on infarct size and left ventricular function
- (2010) Ingo Eitel et al. Clinical Research in Cardiology
- One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial
- (2010) Stefanie Schulz et al. Clinical Research in Cardiology
- Local Delivery Versus Intracoronary Infusion of Abciximab in Patients With Acute Coronary Syndromes
- (2010) Francesco Prati et al. JACC-Cardiovascular Interventions
- Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Abciximab in Patients With Acute ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention After Clopidogrel Loading
- (2009) Julinda Mehilli et al. CIRCULATION
- 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
- (2009) Frederick G. Kushner et al. CIRCULATION
- Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis
- (2009) Dirk Sibbing et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
- (2008) Holger Thiele et al. CIRCULATION
- Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial
- (2008) Arnoud WJ van't Hof et al. LANCET
- Bivalirudin during Primary PCI in Acute Myocardial Infarction
- (2008) Gregg W. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started